Latest news
Loading news…
Axelyf
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Hafnarfjörður, Gullbringusysla, Iceland Founded 2022 1-10 employees For Profit
Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 11
Company Info
- Founded
- 2022
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 4
- HQ
- Hafnarfjörður, Gullbringusysla, Iceland
- Region
- Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 2.7
- Trend (30d)
- 2.9
- Trend (90d)
- -1.2
- Last leadership hire
- Dec 16, 2025
Key People at Axelyf
CEO
Head of Nucleic Acid Technologies & Biology
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Axelyf
Loading news…
FAQs about Axelyf
People who checked this page also checked these
Browse the full Acquirezy directory.